Matthew W. Davis - Chief Development Officer at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Issuer Symbol
AQST on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew W. Davis since 08 Feb 2025

Holdings reported by Matthew W. Davis for Aquestive Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 50,000 $279,500 $5.59 10 Nov 2025 Direct
Non-Qualified Stock Option (right to buy) 50,000 10 Nov 2025 Direct Common Stock

Transactions reported by Matthew W. Davis for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.